The FDA has ordered a halt to the marketing of unapproved single-ingredient oral colchicine, a medication commonly used for the daily prevention of gout, to treat acute gout flare-ups, and for the ...

Patients with gout who are starting urate-lowering therapy, which can trigger a flare, have a lower risk for cardiovascular events when also given colchicine for flare prevention. "Colchicine…, an ...

Share on Pinterest Scientists have repurposed a common gout drug to see if it helps reduce heart attacks and strokes in people with cardiovascular disease. Design by MNT; Photography by Eversame, CC ...